0001214659-17-004735.txt : 20170802
0001214659-17-004735.hdr.sgml : 20170802
20170802171912
ACCESSION NUMBER: 0001214659-17-004735
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20170630
FILED AS OF DATE: 20170802
DATE AS OF CHANGE: 20170802
EFFECTIVENESS DATE: 20170802
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vivo Capital, LLC
CENTRAL INDEX KEY: 0001674712
IRS NUMBER: 203075737
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-17467
FILM NUMBER: 171001251
BUSINESS ADDRESS:
STREET 1: 505 HAMILTON AVENUE, SUITE 207
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: 650-688-0818
MAIL ADDRESS:
STREET 1: 505 HAMILTON AVENUE, SUITE 207
CITY: PALO ALTO
STATE: CA
ZIP: 94301
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001674712
XXXXXXXX
06-30-2017
06-30-2017
false
Vivo Capital, LLC
505 Hamilton Avenue, Suite 207
Palo Alto
CA
94301
13F HOLDINGS REPORT
028-17467
N
Cinthia Sheu
Chief Compliance Officer
650-688-0818
/s / Cinthia Sheu
Palo Alto
CA
08-02-2017
0
26
397070
INFORMATION TABLE
2
infotable.xml
Aclaris therapeutics
Common
00461U105
77524
2858569
SH
SOLE
0
0
2858569
Advanced Accelerator Applications S.A.
Common
00790T100
14007
358786
SH
SOLE
0
0
358786
Agile Therapeutics, Inc.
Common
00847L100
5677
1513975
SH
SOLE
0
0
1513975
Aimmune Therapeutics, Inc.
Common
00900T107
15971
776813
SH
SOLE
0
0
776813
Akari Therapeutics Plc
ADR
00972G108
2433
527842
SH
SOLE
0
0
527842
Ascendis Pharma
ADR
04351P101
49047
1766832
SH
SOLE
0
0
1766832
Aurinia Pharmaceuticals Inc.
Common
05156V102
6211
1013149
SH
SOLE
0
0
1013149
Biohaven Pharmaceutical Holding Company Ltd
Common
0G1196105
49420
1976818
SH
SOLE
0
0
1976818
BioPharmX Corporation
Common
09072X101
6752
14096338
SH
SOLE
0
0
14096338
Capnia, Inc.
Common
14066L105
7362
14695264
SH
SOLE
14695264
0
0
Capnia, Inc.
Warrant
14066L113
159
943858
SH
SOLE
943858
0
0
KalVista Pharmaceuticals, Inc.
Common
048349710
2210
300325
SH
SOLE
0
0
300325
Codexis, Inc.
Common
192005106
28857
5294825
SH
SOLE
0
0
5294825
CRISPR Therapeutics AG
Common
H17182108
2385
148878
SH
SOLE
0
0
148878
Dynavax Technologies Corporation
Common
268158201
3472
359827
SH
SOLE
0
0
359827
Eiger BioPharmaceuticals
Common
28249U105
14118
1787091
SH
SOLE
1787091
0
0
Foamix Pharmaceuticals Ltd.
Common
M46135105
3967
855000
SH
SOLE
0
0
855000
Nabriva Therapeutics AG
ADR
62957M104
42146
4021559
SH
SOLE
0
0
4021559
Sierra Oncology, Inc.
Common
74346L101
2853
2438270
SH
SOLE
0
0
2438270
Regenxbio Inc.
Common
75901B107
3247
164403
SH
SOLE
0
0
164403
ReVance Therapeutics, Inc.
Common
761330109
2043
77373
SH
SOLE
0
0
77373
Selecta Biosciences, Inc.
Common
816212104
22227
1119189
SH
SOLE
0
0
1119189
Strongbridge Biopharma plc
Ordinary Shares
G85347105
21450
3000000
SH
SOLE
0
0
3000000
Sunesis Pharmaceuticals, Inc.
Common
867328700
1350
500000
SH
SOLE
0
0
500000
Trevena, Inc.
Common
89532E109
3974
1728000
SH
SOLE
0
0
1728000
Verona Pharma Plc
ADS
925050106
8208
704225
SH
SOLE
704225
0
0